Regeneron Pharmaceuticals, Inc. (REGN) Handily Tops Q2 EPS Views; Revs Heavy

July 25, 2012 6:34 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q2 EPS of $0.90 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found